{
    "2018-10-29": [
        [
            {
                "time": "",
                "original_text": "川财证券：泰格医药增持评级",
                "features": {
                    "keywords": [
                        "泰格医药",
                        "增持",
                        "评级"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "新版基本药物目录实施在即 六股有掘金机会",
                "features": {
                    "keywords": [
                        "基本药物目录",
                        "实施",
                        "掘金机会"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "【泰格医药】三季报点评：主业继续较快增长，投资项目储备丰富",
                "features": {
                    "keywords": [
                        "泰格医药",
                        "三季报",
                        "主业增长",
                        "投资项目"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药周报: 三季报接近收官, 医药成长依旧, 中线布局好时机",
                "features": {
                    "keywords": [
                        "医药",
                        "三季报",
                        "成长",
                        "中线布局"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}